The European Patent Office (EPO) has upheld two patents issued to US company Intrexon. In these patents, EP1572862 and EP1456346, Intrexon claims genetically engineered animals such as mice, rats, rabbits, cats, dogs, bovines, goats, pigs, horses, sheep, monkeys and chimpanzees as inventions. Together with other organisations, Testbiotech filed an opposition against the patents on ethical grounds, arguing that they can provide incentives to carry out animal experiments for commercial reasons. Testbiotech now will file an appeal against the decision.
Testbiotech brands Intrexon business methods “immoral”
Munich, 25. September 2015 On 29 September, a public hearing will take place in Den Haag on oppositions against patents on genetically engineered chimpanzees held by the US company, Intrexon. In its patents EP1572862 and EP1456346, Intrexon claims animals such as mice, rats, rabbits, cats, dogs, bovines, goats, pigs, horses, sheep, monkeys and chimpanzees as inventions.
Today a legal dossier on the legal status of new methods for the production of genetically engineering plants is published. The dossier, drawn up by Professor Ludwig Kraemer, is being presented ahead of a decision due to be announced by the EU Commission within the next few weeks. Industry is demanding that new methods of changing genetic conditions in plants and animals should not be regulated in the same way as genetically engineered plants, and should be allowed onto the market without registration, risk assessment or labelling.
Testbiotech will today publish a report providing a global overview of recent cases of uncontrolled spread of genetically engineered organisms able to persist and propagate in the environment. The report will be presented to a working group organised by the Secretary of the Convention of Biological Diversity (CBD) at a meeting taking place in Montreal (Canada) from 21 - 25 September.